ANIP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $7,062,704.98

ANI Pharmaceuticals Insider Trading History Chart

ANI Pharmaceuticals Share Price & Price History

^$64.66

▲ +1.31 (2.07%)

As of 06/18/2025 05:00 PM ET

Days: 30 | 90 | 365

ANI Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/13/2025	Meredith Cook	VP	Sell	400	$61.37	$24,548.00	79,345
5/15/2025	Ori Gutwerg	SVP	Sell	881	$60.07	$52,921.67	89,897
5/14/2025	Christopher Mutz	Insider	Sell	4,000	$60.45	$241,800.00	107,317
4/14/2025	Meredith Cook	VP	Sell	400	$68.96	$27,584.00	80,145
3/13/2025	Meredith Cook	VP	Sell	400	$63.33	$25,332.00	80,545
3/7/2025	Krista Davis	SVP	Sell	1,000	$60.86	$60,860.00	66,525
2/21/2025	Krista Davis	SVP	Sell	1,000	$60.20	$60,200.00	68,624
2/13/2025	Meredith Cook	VP	Sell	400	$59.54	$23,816.00	83,478
1/13/2025	Meredith Cook	VP	Sell	400	$53.92	$21,568.00	55,588
12/17/2024	Stephen P. Carey	CFO	Sell	7,500	$55.79	$418,425.00	154,468
12/11/2024	Krista Davis	SVP	Sell	1,000	$60.00	$60,000.00	49,059
11/26/2024	Nikhil Lalwani	CEO	Sell	33,481	$57.99	$1,941,563.19	370,378
10/14/2024	Meredith Cook	VP	Sell	250	$57.19	$14,297.50	56,488
9/13/2024	Meredith Cook	VP	Sell	250	$56.82	$14,205.00	56,738
8/13/2024	Meredith Cook	VP	Sell	250	$59.62	$14,905.00	56,988
7/17/2024	Muthusamy Shanmugam	COO	Sell	14,257	$63.16	$900,472.12	635,363
7/15/2024	Muthusamy Shanmugam	COO	Sell	11,000	$63.38	$697,180.00	671,620
7/12/2024	Meredith Cook	VP	Sell	250	$64.91	$16,227.50	58,981
7/1/2024	Chad Gassert	SVP	Sell	20,000	$63.44	$1,268,800.00	193,226
6/21/2024	Muthusamy Shanmugam	COO	Sell	20,000	$58.90	$1,178,000.00	682,620
6/13/2024	Meredith Cook	VP	Sell	250	$63.80	$15,950.00	59,231
6/5/2024	Ori Gutwerg	SVP	Sell	2,985	$67.00	$199,995.00	77,227
6/4/2024	Stephen P. Carey	CFO	Sell	5,000	$63.58	$317,900.00	161,968
6/3/2024	Chad Gassert	SVP	Sell	20,000	$64.41	$1,288,200.00	213,226
5/21/2024	Christopher Mutz	Insider	Sell	2,000	$61.61	$123,220.00	83,277
5/20/2024	Muthusamy Shanmugam	COO	Sell	12,855	$61.81	$794,567.55	732,620
5/17/2024	Muthusamy Shanmugam	COO	Sell	5,836	$62.09	$362,357.24	745,475
5/16/2024	Renee P. Tannenbaum	Director	Sell	2,000	$63.87	$127,740.00	18,211
5/15/2024	Muthusamy Shanmugam	COO	Sell	14,850	$65.86	$978,021.00	767,770
5/14/2024	Nikhil Lalwani	CEO	Sell	16,669	$66.10	$1,101,820.90	377,505
5/13/2024	Meredith Cook	VP	Sell	250	$67.69	$16,922.50	59,481
5/1/2024	Chad Gassert	SVP	Sell	20,000	$66.62	$1,332,400.00	233,226
4/19/2024	Muthusamy Shanmugam	COO	Sell	16,809	$65.17	$1,095,442.53	782,620
4/17/2024	Muthusamy Shanmugam	COO	Sell	9,520	$65.40	$622,608.00	809,852
4/15/2024	Muthusamy Shanmugam	COO	Sell	7,414	$66.33	$491,770.62	825,206
4/12/2024	Meredith Cook	VP	Sell	250	$67.79	$16,947.50	59,731
4/1/2024	Chad Gassert	SVP	Sell	20,000	$67.25	$1,345,000.00	253,226
3/11/2024	Stephen P. Carey	CFO	Sell	7,787	$65.55	$510,437.85	177,712
3/8/2024	Nikhil Lalwani	CEO	Sell	16,292	$67.13	$1,093,681.96	411,629
3/7/2024	James G. Marken	SVP	Sell	24,338	$66.37	$1,615,313.06	124,492
3/7/2024	Muthusamy Shanmugam	COO	Sell	15,085	$66.35	$1,000,889.75	842,620
3/6/2024	Nikhil Lalwani	CEO	Sell	28,965	$65.52	$1,897,786.80	444,981
3/5/2024	Muthusamy Shanmugam	COO	Sell	10,093	$65.35	$659,577.55	872,527
2/13/2024	Meredith Cook	VP	Sell	250	$56.04	$14,010.00	36,799
1/22/2024	Muthusamy Shanmugam	COO	Sell	5,692	$55.95	$318,467.40	897,620
1/18/2024	Muthusamy Shanmugam	COO	Sell	9,784	$55.30	$541,055.20	907,836
1/16/2024	Muthusamy Shanmugam	COO	Sell	5,000	$55.63	$278,150.00	927,620
1/12/2024	Meredith Cook	VP	Sell	250	$56.43	$14,107.50	37,049
12/18/2023	Muthusamy Shanmugam	COO	Sell	13,026	$52.44	$683,083.44	957,620
12/15/2023	Muthusamy Shanmugam	COO	Sell	11,974	$52.44	$627,916.56	970,646
12/11/2023	Meredith Cook	VP	Sell	250	$49.21	$12,302.50	37,299
11/16/2023	Muthusamy Shanmugam	COO	Sell	6,448	$51.66	$333,103.68	996,430
11/15/2023	Krista Davis	SVP	Sell	2,622	$53.81	$141,089.82	32,587
11/14/2023	Muthusamy Shanmugam	COO	Sell	22,095	$53.17	$1,174,791.15	1,010,525
10/18/2023	Muthusamy Shanmugam	COO	Sell	6,242	$57.78	$360,662.76	1,042,620
10/16/2023	Muthusamy Shanmugam	COO	Sell	13,063	$58.31	$761,703.53	1,057,620
10/13/2023	Muthusamy Shanmugam	COO	Sell	11,937	$57.58	$687,332.46	1,070,683
10/2/2023	Chad Gassert	SVP	Sell	20,000	$56.48	$1,129,600.00	293,226
9/18/2023	Muthusamy Shanmugam	COO	Sell	8,425	$61.64	$519,317.00	1,107,953
9/15/2023	Muthusamy Shanmugam	COO	Sell	16,242	$62.81	$1,020,160.02	1,116,378
9/1/2023	Chad Gassert	SVP	Sell	20,000	$64.70	$1,294,000.00	313,226
8/28/2023	Muthusamy Shanmugam	COO	Sell	25,000	$63.06	$1,576,500.00	1,157,620
8/23/2023	Ori Gutwerg	SVP	Sell	15,561	$62.39	$970,850.79	60,915
8/16/2023	Meridian Venture Partners Ii L	Major Shareholder	Sell	200,000	$58.50	$11,700,000.00	1,819,259
8/15/2023	Nikhil Lalwani	CEO	Sell	11,616	$61.13	$710,086.08	353,390
8/14/2023	Antonio R. Pera	Director	Sell	3,000	$60.37	$181,110.00	33,627
8/14/2023	Muthusamy Shanmugam	COO	Sell	27,890	$61.15	$1,705,473.50	1,204,730
8/11/2023	Nikhil Lalwani	CEO	Sell	56,666	$57.75	$3,272,461.50	353,390
8/1/2023	Chad Gassert	SVP	Sell	20,000	$51.06	$1,021,200.00	333,226
7/21/2023	Muthusamy Shanmugam	COO	Sell	11,500	$52.56	$604,440.00	1,232,620
7/19/2023	Muthusamy Shanmugam	COO	Sell	5,969	$51.48	$307,284.12	1,250,120
7/17/2023	Muthusamy Shanmugam	COO	Sell	9,831	$51.06	$501,970.86	1,262,789
7/14/2023	Muthusamy Shanmugam	COO	Sell	10,000	$50.43	$504,300.00	1,272,620
7/3/2023	Chad Gassert	SVP	Sell	20,000	$53.43	$1,068,600.00	353,226
6/22/2023	Chad Gassert	SVP	Sell	20,000	$51.32	$1,026,400.00	373,226
6/22/2023	Muthusamy Shanmugam	COO	Sell	13,500	$51.38	$693,630.00	7,407
6/20/2023	Muthusamy Shanmugam	COO	Sell	14,657	$51.93	$761,138.01	32,750
8/15/2022	James G. Marken	SVP	Sell	5,172	$37.79	$195,449.88	117,642
8/12/2022	James G. Marken	SVP	Sell	12,894	$37.04	$477,593.76	122,814

SEC Filings (Institutional Ownership Changes) for ANI Pharmaceuticals (NASDAQ:ANIP)

76.05% of ANI Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ANI Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/18/2025	Voya Investment Management LLC	8,934	$0.60M	0.0%	+12.0%	0.041%
5/29/2025	Rhumbline Advisers	41,323	$2.77M	0.0%	-1.6%	0.191%
5/19/2025	Jane Street Group LLC	40,423	$2.71M	0.0%	N/A	0.186%
5/19/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	48,322	$3.24M	0.0%	+0.9%	0.222%
5/16/2025	Woodline Partners LP	166,448	$11.14M	0.1%	N/A	0.764%
5/16/2025	Great Lakes Advisors LLC	66,836	$4.48M	0.0%	-10.0%	0.307%
5/16/2025	Goldman Sachs Group Inc.	631,786	$42.30M	0.0%	-9.7%	2.902%
5/16/2025	Parkman Healthcare Partners LLC	105,000	$7.03M	0.8%	N/A	0.482%
5/16/2025	Millennium Management LLC	818,341	$54.79M	0.0%	-18.4%	3.758%
5/16/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	10,993	$0.74M	0.0%	+4.5%	0.050%
5/16/2025	AQR Capital Management LLC	14,066	$0.94M	0.0%	-12.6%	0.065%
5/16/2025	Advisors Asset Management Inc.	425	$28K	0.0%	N/A	0.002%
5/16/2025	AYAL Capital Advisors Ltd	66,715	$4.47M	1.5%	N/A	0.306%
5/15/2025	Federation des caisses Desjardins du Quebec	24,275	$1.63M	0.0%	+15.3%	0.111%
5/15/2025	Apis Capital Advisors LLC	65,000	$4.35M	2.1%	N/A	0.299%
5/15/2025	Nomura Holdings Inc.	217,176	$14.54M	0.0%	+1.5%	0.997%
5/14/2025	Corebridge Financial Inc.	9,595	$0.64M	0.0%	-1.9%	0.044%
5/14/2025	Virtus Advisers LLC	13,771	$0.92M	1.2%	N/A	0.063%
5/14/2025	Comerica Bank	11,550	$0.77M	0.0%	-38.7%	0.053%
5/14/2025	MetLife Investment Management LLC	11,219	$0.75M	0.0%	-1.6%	0.052%
5/14/2025	Stonepine Capital Management LLC	48,000	$3.21M	3.1%	+135.3%	0.220%
5/14/2025	Walleye Capital LLC	31,284	$2.09M	0.0%	-56.6%	0.144%
5/14/2025	Penn Capital Management Company LLC	6,696	$0.45M	0.0%	N/A	0.031%
5/14/2025	Jump Financial LLC	23,221	$1.56M	0.0%	N/A	0.107%
5/14/2025	Hotchkis & Wiley Capital Management LLC	108,600	$7.27M	0.0%	+89.9%	0.499%
5/14/2025	Advantage Alpha Capital Partners LP	10,199	$0.68M	0.2%	+37,674.1%	0.047%
5/14/2025	Martingale Asset Management L P	23,615	$1.58M	0.0%	-9.8%	0.108%
5/14/2025	Quantbot Technologies LP	19,585	$1.31M	0.0%	N/A	0.090%
5/14/2025	Wellington Management Group LLP	8,206	$0.55M	0.0%	N/A	0.038%
5/13/2025	Northern Trust Corp	216,862	$14.52M	0.0%	+6.1%	0.996%
5/13/2025	Raymond James Financial Inc.	100,164	$6.71M	0.0%	+41.4%	0.460%
5/13/2025	American Century Companies Inc.	25,837	$1.73M	0.0%	-57.1%	0.119%
5/13/2025	Aberdeen Group plc	419,099	$28.06M	0.1%	+76.1%	1.925%
5/13/2025	Mitsubishi UFJ Asset Management UK Ltd.	5,000	$0.34M	0.2%	N/A	0.023%
5/13/2025	Russell Investments Group Ltd.	185,475	$12.42M	0.0%	+32.0%	0.852%
5/12/2025	Public Sector Pension Investment Board	52,668	$3.53M	0.0%	+27.3%	0.242%
5/12/2025	Nuveen LLC	48,601	$3.25M	0.0%	N/A	0.223%
5/12/2025	Invesco Ltd.	199,567	$13.36M	0.0%	+1.0%	0.917%
5/12/2025	Mizuho Markets Americas LLC	197,473	$13.22M	0.3%	-1.6%	0.907%
5/12/2025	Global Alpha Capital Management Ltd.	735,590	$49.25M	3.6%	+17.8%	3.378%
5/12/2025	Connor Clark & Lunn Investment Management Ltd.	46,750	$3.13M	0.0%	+202.7%	0.215%
5/12/2025	National Bank of Canada FI	1,177	$79K	0.0%	N/A	0.005%
5/12/2025	Maryland State Retirement & Pension System	4,857	$0.33M	0.0%	-13.3%	0.022%
5/9/2025	Headlands Technologies LLC	5,369	$0.36M	0.0%	+348.2%	0.025%
5/9/2025	Deutsche Bank AG	218,086	$14.60M	0.0%	-6.1%	1.002%
5/9/2025	Charles Schwab Investment Management Inc.	238,377	$15.96M	0.0%	+0.9%	1.095%
5/9/2025	Vanguard Group Inc.	1,181,471	$79.10M	0.0%	-10.1%	5.426%
5/8/2025	Mesirow Financial Investment Management Inc.	2,996	$0.21M	0.0%	N/A	0.014%
5/6/2025	1492 Capital Management LLC	7,883	$0.53M	0.3%	-3.6%	0.036%
5/6/2025	Wakefield Asset Management LLLP	17,248	$1.16M	0.3%	N/A	0.079%
5/6/2025	Legato Capital Management LLC	18,050	$1.21M	0.2%	+198.8%	0.083%
5/6/2025	Universal Beteiligungs und Servicegesellschaft mbH	56,664	$3.79M	0.0%	N/A	0.260%
5/5/2025	Allianz Asset Management GmbH	6,200	$0.42M	0.0%	N/A	0.028%
5/2/2025	Segall Bryant & Hamill LLC	41,415	$2.77M	0.0%	-4.7%	0.190%
5/2/2025	Victory Capital Management Inc.	16,863	$1.13M	0.0%	+22.4%	0.077%
5/2/2025	Hohimer Wealth Management LLC	4,989	$0.33M	0.1%	+5.2%	0.023%
5/1/2025	Rice Hall James & Associates LLC	58,589	$3.92M	0.2%	-0.6%	0.269%
5/1/2025	Louisiana State Employees Retirement System	7,800	$0.52M	0.0%	-2.5%	0.036%
5/1/2025	New York State Common Retirement Fund	6,524	$0.44M	0.0%	-15.1%	0.030%
4/29/2025	Envestnet Asset Management Inc.	6,457	$0.43M	0.0%	+31.0%	0.030%
4/29/2025	Bank of New York Mellon Corp	119,262	$7.99M	0.0%	-3.7%	0.548%
4/28/2025	Principal Financial Group Inc.	157,798	$10.57M	0.0%	+68.3%	0.725%
4/28/2025	Teacher Retirement System of Texas	4,526	$0.30M	0.0%	-9.5%	0.021%
4/25/2025	Lisanti Capital Growth LLC	105,425	$7.06M	2.1%	+291.8%	0.484%
4/24/2025	Decker Retirement Planning Inc.	26,953	$1.81M	1.1%	N/A	0.124%
4/24/2025	Allspring Global Investments Holdings LLC	8,949	$0.60M	0.0%	+53.3%	0.041%
4/24/2025	Illinois Municipal Retirement Fund	8,162	$0.55M	0.0%	-4.3%	0.037%
4/21/2025	State of Alaska Department of Revenue	9,196	$0.62M	0.0%	-2.3%	0.042%
4/17/2025	Sowell Financial Services LLC	5,262	$0.35M	0.0%	N/A	0.024%
4/15/2025	Assenagon Asset Management S.A.	114,618	$7.67M	0.0%	-63.2%	0.526%
4/15/2025	GAMMA Investing LLC	1,419	$95K	0.0%	+163.8%	0.007%
4/14/2025	Wedge Capital Management L L P NC	24,168	$1.62M	0.0%	-25.0%	0.111%
4/8/2025	Rhumbline Advisers	41,323	$2.77M	0.0%	-1.6%	0.190%
4/8/2025	BTC Capital Management Inc.	8,256	$0.55M	0.1%	-22.3%	0.038%
4/7/2025	Summit Global Investments	16,306	$1.09M	0.1%	-16.4%	0.075%
4/7/2025	GAMMA Investing LLC	95,002	$6.36M	0.0%	+17,558.4%	0.436%
4/4/2025	Kings Path Partners LLC	11,913	$0.80M	0.4%	-38.6%	0.055%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	47,899	$2.65M	0.0%	+41.1%	0.228%
2/17/2025	Soleus Capital Management L.P.	205,294	$11.35M	0.7%	-23.7%	0.976%
2/17/2025	Stonepine Capital Management LLC	20,400	$1.13M	0.9%	N/A	0.097%
2/17/2025	Tang Capital Management LLC	317,500	$17.55M	1.2%	-29.4%	1.510%
2/17/2025	Rafferty Asset Management LLC	3,622	$0.20M	0.0%	N/A	0.017%
2/17/2025	ProShare Advisors LLC	6,532	$0.36M	0.0%	+29.0%	0.031%
2/17/2025	Nomura Holdings Inc.	213,879	$11.82M	0.0%	+1.5%	1.017%
2/17/2025	Nuveen Asset Management LLC	49,643	$2.74M	0.0%	-72.7%	0.236%
2/17/2025	Millennium Management LLC	1,002,849	$55.44M	0.0%	+89.3%	4.769%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	10,523	$0.58M	0.0%	+3.6%	0.050%
2/17/2025	Lazard Asset Management LLC	1,781	$97K	0.0%	-68.2%	0.008%
2/17/2025	Graham Capital Management L.P.	6,358	$0.35M	0.0%	N/A	0.030%
2/17/2025	D. E. Shaw & Co. Inc.	196,319	$10.85M	0.0%	+80.7%	0.934%
2/17/2025	Deutsche Bank AG	232,328	$12.84M	0.0%	-0.1%	1.105%
2/17/2025	Deep Track Capital LP	649,042	$35.88M	1.3%	+28.6%	3.086%
2/17/2025	Bridgefront Capital LLC	3,692	$0.20M	0.1%	N/A	0.018%
2/17/2025	Balyasny Asset Management L.P.	38,488	$2.14M	0.0%	N/A	0.183%
2/17/2025	Bank of America Corp DE	95,160	$5.26M	0.0%	+45.1%	0.452%
2/17/2025	BNP Paribas Financial Markets	4,335	$0.24M	0.0%	-45.3%	0.021%
2/17/2025	Ameriprise Financial Inc.	271,805	$15.03M	0.0%	+14.6%	1.292%
2/14/2025	Freestone Grove Partners LP	4,679	$0.26M	0.0%	N/A	0.022%
2/14/2025	Comerica Bank	18,830	$1.04M	0.0%	-30.1%	0.090%
2/14/2025	Northern Trust Corp	204,345	$11.30M	0.0%	+9.0%	0.972%

Data available starting January 2016

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Today's Range

Now: $64.66

$62.81

$65.63

50 Day Range

MA: $64.71

$57.27

$72.95

52 Week Range

Now: $64.66

$52.50

$77.00

Volume

344,202 shs

Average Volume

327,855 shs

Market Capitalization

$1.40 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.55

Who are the company insiders with the largest holdings of ANI Pharmaceuticals?: ANI Pharmaceuticals' top insider shareholders include:
Meridian Venture Partners Ii L (Major Shareholder)
Muthusamy Shanmugam (COO)
Nikhil Lalwani (CEO)
Chad Gassert (SVP)
Stephen P Carey (CFO)
James G Marken (SVP)
Christopher Mutz (Insider)
Ori Gutwerg (SVP)
Meredith Cook (VP)
Krista Davis (SVP)
Antonio R Pera (Director)
Renee P Tannenbaum (Director)
Learn More about top insider investors at ANI Pharmaceuticals.
Who are the major institutional investors of ANI Pharmaceuticals?: ANI Pharmaceuticals' top institutional investors include:
Vanguard Group Inc. — 5.43%
Millennium Management LLC — 3.76%
Global Alpha Capital Management Ltd. — 3.38%
Goldman Sachs Group Inc. — 2.90%
Aberdeen Group plc — 1.92%
Charles Schwab Investment Management Inc. — 1.09%
Learn More about top institutional investors of ANI Pharmaceuticals stock.
Which major investors are selling ANI Pharmaceuticals stock?: Within the previous quarter, ANIP stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Millennium Management LLC
Vanguard Group Inc.
Goldman Sachs Group Inc.
Walleye Capital LLC
American Century Companies Inc.
Deutsche Bank AG
Wedge Capital Management L L P NC
Within the previous year, company insiders that have sold ANI Pharmaceuticals company stock include:
Meridian Venture Partners Ii L (Major Shareholder)
Muthusamy Shanmugam (COO)
Nikhil Lalwani (CEO)
Chad Gassert (SVP)
Stephen P Carey (CFO)
James G Marken (SVP)
Christopher Mutz (Insider)
Ori Gutwerg (SVP)
Learn More investors selling ANI Pharmaceuticals stock.
Which major investors are buying ANI Pharmaceuticals stock?: Within the last quarter, ANIP stock was purchased by institutional investors including:
Aberdeen Group plc
Woodline Partners LP
Global Alpha Capital Management Ltd.
Parkman Healthcare Partners LLC
GAMMA Investing LLC
Lisanti Capital Growth LLC
AYAL Capital Advisors Ltd
Apis Capital Advisors LLC